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Our preliminary screening had shown that the curcumin derivative [2,6-bis(2,5- 
dimethoxybenzylidene)cyclohexanone] or BDMC33 exhibited improved anti-inflammatory 
activity by inhibiting nitric oxide synthesis in activated macrophage cells. In this study, we 
further investigated the anti-inflammatory properties of BDMC33 on PGE 2 synthesis and 
cyclooxygenase (COX) expression in IFN-γ/LPS-stimulated macrophages. We found that 
BDMC33 significantly inhibited PGE 2 synthesis in a concentration-dependent manner albeit 
at a low inhibition level with an IC 50 value of 47.33 ± 1.00 μM. Interestingly, the PGE2 
inhibitory activity of BDMC33 is not attributed to inhibition of the COX enzyme activities, 
but rather BDMC33 selectively down-regulated the expression of COX-2. In addition, 
BDMC33 modulates the COX expression by sustaining the constitutively COX-1 expression 
in IFN-γ/LPS-treated macrophage cells. Collectively, the experimental data suggest an 
immunodulatory action of BDMC33 on PGE 2 synthesis and COX expression, making it a 
possible treatment for inflammatory disorders with minimal gastrointestinal related side 
effects. 
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